Cite
MLA Citation
Z.Z.N. Yiu et al.. “Infliximab is associated with an increased risk of serious infection in patients with psoriasis in the U.K. and Republic of Ireland: results from the British Association of Dermatologists Biologic Interventions Register (BADBIR).” British journal of dermatology, vol. 180, 2019, pp. 329–337. http://access.bl.uk/ark:/81055/vdc_100077450682.0x000060